 | • レポートコード：MRC309Z7989 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の標的DNA修復薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の標的DNA修復薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 標的DNA修復薬の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 標的DNA修復薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他 用途別セグメント ・卵巣がん、卵管がん、腹膜がん、乳がん、その他 主要な市場プレーヤー ・Onxeo、FoRx Therapeutics、Artios Pharma Limited、Merck KGaA、Breakpoint Therapeutics、Luciole Pharmaceuticals、AstraZeneca、AbbVie、Johnson & Johnson、Pfizer、ClovisOncology、GlaxoSmithKline 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、標的DNA修復薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な標的DNA修復薬メーカーの企業概要、2019年～2022年までの標的DNA修復薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な標的DNA修復薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別標的DNA修復薬の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの標的DNA修復薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での標的DNA修復薬市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および標的DNA修復薬の産業チェーンを掲載しています。 ・第14、15章では、標的DNA修復薬の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 標的DNA修復薬の概要 - 種類別分析（2018年vs2022年vs2029年）：オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他 - 用途別分析（2018年vs2022年vs2029年）：卵巣がん、卵管がん、腹膜がん、乳がん、その他 - 世界の標的DNA修復薬市場規模・予測 - 世界の標的DNA修復薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Onxeo、FoRx Therapeutics、Artios Pharma Limited、Merck KGaA、Breakpoint Therapeutics、Luciole Pharmaceuticals、AstraZeneca、AbbVie、Johnson & Johnson、Pfizer、ClovisOncology、GlaxoSmithKline ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他 ・用途別分析2018年-2029年：卵巣がん、卵管がん、腹膜がん、乳がん、その他 ・標的DNA修復薬の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・標的DNA修復薬のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・標的DNA修復薬のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・標的DNA修復薬の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・標的DNA修復薬の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Targeting DNA Repair Drugs market size was valued at USD 615.3 million in 2022 and is forecast to a readjusted size of USD 1629.7 million by 2029 with a CAGR of 14.9% during review period.
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.
In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .
The Global Info Research report includes an overview of the development of the Targeting DNA Repair Drugs industry chain, the market status of Ovarian Cancer (Olaparib, Rucaparib), Fallopian Tube Cancer (Olaparib, Rucaparib), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeting DNA Repair Drugs.
Regionally, the report analyzes the Targeting DNA Repair Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeting DNA Repair Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeting DNA Repair Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeting DNA Repair Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Olaparib, Rucaparib).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeting DNA Repair Drugs market.
Regional Analysis: The report involves examining the Targeting DNA Repair Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeting DNA Repair Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeting DNA Repair Drugs:
Company Analysis: Report covers individual Targeting DNA Repair Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeting DNA Repair Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Ovarian Cancer, Fallopian Tube Cancer).
Technology Analysis: Report covers specific technologies relevant to Targeting DNA Repair Drugs. It assesses the current state, advancements, and potential future developments in Targeting DNA Repair Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeting DNA Repair Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeting DNA Repair Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Olaparib
Rucaparib
Niraparib
Talazoparib
Others
Market segment by Application
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Breast Cancer
Others
Major players covered
Onxeo
FoRx Therapeutics
Artios Pharma Limited
Merck KGaA
Breakpoint Therapeutics
Luciole Pharmaceuticals
AstraZeneca
AbbVie
Johnson & Johnson
Pfizer
ClovisOncology
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeting DNA Repair Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeting DNA Repair Drugs, with price, sales, revenue and global market share of Targeting DNA Repair Drugs from 2018 to 2023.
Chapter 3, the Targeting DNA Repair Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeting DNA Repair Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeting DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeting DNA Repair Drugs.
Chapter 14 and 15, to describe Targeting DNA Repair Drugs sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Targeting DNA Repair Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Olaparib
1.3.3 Rucaparib
1.3.4 Niraparib
1.3.5 Talazoparib
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Ovarian Cancer
1.4.3 Fallopian Tube Cancer
1.4.4 Peritoneal Cancer
1.4.5 Breast Cancer
1.4.6 Others
1.5 Global Targeting DNA Repair Drugs Market Size & Forecast
1.5.1 Global Targeting DNA Repair Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeting DNA Repair Drugs Sales Quantity (2018-2029)
1.5.3 Global Targeting DNA Repair Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Onxeo
2.1.1 Onxeo Details
2.1.2 Onxeo Major Business
2.1.3 Onxeo Targeting DNA Repair Drugs Product and Services
2.1.4 Onxeo Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Onxeo Recent Developments/Updates
2.2 FoRx Therapeutics
2.2.1 FoRx Therapeutics Details
2.2.2 FoRx Therapeutics Major Business
2.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Product and Services
2.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 FoRx Therapeutics Recent Developments/Updates
2.3 Artios Pharma Limited
2.3.1 Artios Pharma Limited Details
2.3.2 Artios Pharma Limited Major Business
2.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Product and Services
2.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Artios Pharma Limited Recent Developments/Updates
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Targeting DNA Repair Drugs Product and Services
2.4.4 Merck KGaA Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck KGaA Recent Developments/Updates
2.5 Breakpoint Therapeutics
2.5.1 Breakpoint Therapeutics Details
2.5.2 Breakpoint Therapeutics Major Business
2.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Product and Services
2.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Breakpoint Therapeutics Recent Developments/Updates
2.6 Luciole Pharmaceuticals
2.6.1 Luciole Pharmaceuticals Details
2.6.2 Luciole Pharmaceuticals Major Business
2.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product and Services
2.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Luciole Pharmaceuticals Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Targeting DNA Repair Drugs Product and Services
2.7.4 AstraZeneca Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Targeting DNA Repair Drugs Product and Services
2.8.4 AbbVie Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments/Updates
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Targeting DNA Repair Drugs Product and Services
2.9.4 Johnson & Johnson Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments/Updates
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Targeting DNA Repair Drugs Product and Services
2.10.4 Pfizer Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments/Updates
2.11 ClovisOncology
2.11.1 ClovisOncology Details
2.11.2 ClovisOncology Major Business
2.11.3 ClovisOncology Targeting DNA Repair Drugs Product and Services
2.11.4 ClovisOncology Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ClovisOncology Recent Developments/Updates
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Product and Services
2.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GlaxoSmithKline Recent Developments/Updates
3 Competitive Environment: Targeting DNA Repair Drugs by Manufacturer
3.1 Global Targeting DNA Repair Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeting DNA Repair Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Targeting DNA Repair Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeting DNA Repair Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.5 Targeting DNA Repair Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeting DNA Repair Drugs Market: Region Footprint
3.5.2 Targeting DNA Repair Drugs Market: Company Product Type Footprint
3.5.3 Targeting DNA Repair Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Targeting DNA Repair Drugs Market Size by Region
4.1.1 Global Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Targeting DNA Repair Drugs Average Price by Region (2018-2029)
4.2 North America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.3 Europe Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.5 South America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Targeting DNA Repair Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
5.2 Global Targeting DNA Repair Drugs Consumption Value by Type (2018-2029)
5.3 Global Targeting DNA Repair Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
6.2 Global Targeting DNA Repair Drugs Consumption Value by Application (2018-2029)
6.3 Global Targeting DNA Repair Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
7.2 North America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
7.3 North America Targeting DNA Repair Drugs Market Size by Country
7.3.1 North America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Targeting DNA Repair Drugs Market Size by Country
8.3.1 Europe Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeting DNA Repair Drugs Market Size by Region
9.3.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
10.2 South America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
10.3 South America Targeting DNA Repair Drugs Market Size by Country
10.3.1 South America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeting DNA Repair Drugs Market Size by Country
11.3.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Targeting DNA Repair Drugs Market Drivers
12.2 Targeting DNA Repair Drugs Market Restraints
12.3 Targeting DNA Repair Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Targeting DNA Repair Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeting DNA Repair Drugs
13.3 Targeting DNA Repair Drugs Production Process
13.4 Targeting DNA Repair Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeting DNA Repair Drugs Typical Distributors
14.3 Targeting DNA Repair Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
